Mengyun Peng
P.R. China
Luzhou, 646000, China
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Heshuxiaoji pill suppresses steatohepatitis and fibrosis by regulating the AngII-BACH1 mediated vasoconstriction.
Journal: Journal of ethnopharmacology
Published: January 26, 2025
Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis.
Journal: Frontiers in medicine
Published: July 11, 2024
Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation.
Journal: Pharmaceutical biology
Published: March 13, 2023
Identification of a novel ANK1 mutation in a Chinese family with hereditary spherocytosis: A case report.
Journal: Experimental and therapeutic medicine
Published: August 04, 2022
Effects of Qutan Huoxue Formula on the SOCS1/TLR4 Signaling Pathway in NASH Model Mice.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: May 07, 2020
Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats.
Effects of Qutanhuoxue Decoction on AQP7 and AQP9 Expression in Nonalcoholic Fatty Liver Model Rats.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: November 09, 2018
Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis.
Journal: Canadian journal of gastroenterology & hepatology
Published: December 09, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026